Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Corrigendum re "Neoadjuvant Short-term Intensive Intravesical Mitomycin C Regimen Compared with Weekly Schedule for Low-grade Recurrent Non-muscle-invasive Bladder Cancer: Preliminary Results of a Randomised Phase 2 Study" [Eur Urol 2012;62:797-802].

Colombo R, Rocchini L, Suardi N, Benigni F, Colciago G, Bettiga A, Pellucchi F, Maccagnano C, Briganti A, Salonia A, Rigatti P, Montorsi F.

Eur Urol. 2019 Mar;75(3):e81. doi: 10.1016/j.eururo.2018.09.012. Epub 2018 Nov 5. No abstract available.

PMID:
30409675
2.

Expression and distribution of key proteins of the endocannabinoid system in the human seminal vesicles.

Ückert S, la Croce G, Bettiga A, Albrecht K, Buono R, Benigni F, Kuczyk MA, Hedlund P.

Andrologia. 2018 Mar;50(2). doi: 10.1111/and.12875. Epub 2017 Aug 8.

PMID:
28786134
3.

The Association of Uromodulin Genotype with Renal Cancer Aggressiveness.

Trevisani F, Larcher A, Cinque A, Capitanio U, Ripa F, Vago R, Bettiga A, Benigni F, Carenzi C, Muttin F, Bertini R, Briganti A, Salonia A, Rampoldi L, Montorsi F.

Eur Urol Focus. 2019 Mar;5(2):262-265. doi: 10.1016/j.euf.2017.04.009. Epub 2017 May 12.

PMID:
28753889
4.

Bladder cancer cell growth and motility implicate cannabinoid 2 receptor-mediated modifications of sphingolipids metabolism.

Bettiga A, Aureli M, Colciago G, Murdica V, Moschini M, Lucianò R, Canals D, Hannun Y, Hedlund P, Lavorgna G, Colombo R, Bassi R, Samarani M, Montorsi F, Salonia A, Benigni F.

Sci Rep. 2017 Feb 13;7:42157. doi: 10.1038/srep42157.

5.

Development of new inhibitors for N-acylethanolamine-hydrolyzing acid amidase as promising tool against bladder cancer.

Vago R, Bettiga A, Salonia A, Ciuffreda P, Ottria R.

Bioorg Med Chem. 2017 Feb 1;25(3):1242-1249. doi: 10.1016/j.bmc.2016.12.042. Epub 2016 Dec 27.

PMID:
28062195
6.

Ouabain Contributes to Kidney Damage in a Rat Model of Renal Ischemia-Reperfusion Injury.

Villa L, Buono R, Ferrandi M, Molinari I, Benigni F, Bettiga A, Colciago G, Ikehata M, Messaggio E, Rastaldi MP, Montorsi F, Salonia A, Manunta P.

Int J Mol Sci. 2016 Oct 14;17(10). pii: E1728.

7.

DFL23448, A Novel Transient Receptor Potential Melastin 8-Selective Ion Channel Antagonist, Modifies Bladder Function and Reduces Bladder Overactivity in Awake Rats.

Mistretta FA, Russo A, Castiglione F, Bettiga A, Colciago G, Montorsi F, Brandolini L, Aramini A, Bianchini G, Allegretti M, Bovolenta S, Russo R, Benigni F, Hedlund P.

J Pharmacol Exp Ther. 2016 Jan;356(1):200-11. doi: 10.1124/jpet.115.228684. Epub 2015 Nov 6.

PMID:
26546575
8.

Pelvic nerve injury negatively impacts female genital blood flow and induces vaginal fibrosis-implications for human nerve-sparing radical hysterectomy.

Castiglione F, Bergamini A, Albersen M, Hannan JL, Bivalacqua TJ, Bettiga A, Benigni F, Salonia A, Montorsi F, Hedlund P.

BJOG. 2015 Oct;122(11):1457-65. doi: 10.1111/1471-0528.13506. Epub 2015 Jul 14.

9.

Mesenchymal stem cells expressing therapeutic genes induce autochthonous prostate tumour regression.

Abrate A, Buono R, Canu T, Esposito A, Del Maschio A, Lucianò R, Bettiga A, Colciago G, Guazzoni G, Benigni F, Hedlund P, Altaner C, Montorsi F, Cavarretta IT.

Eur J Cancer. 2014 Sep;50(14):2478-88. doi: 10.1016/j.ejca.2014.06.014. Epub 2014 Jul 21.

PMID:
25060826
10.

The fatty acid amide hydrolase inhibitor oleoyl ethyl amide counteracts bladder overactivity in female rats.

Gandaglia G, Strittmatter F, La Croce G, Benigni F, Bettiga A, Castiglione F, Moschini M, Mistretta F, Gratzke C, Montorsi F, Stief C, Hedlund P.

Neurourol Urodyn. 2014 Nov;33(8):1251-8. doi: 10.1002/nau.22482. Epub 2013 Aug 29.

PMID:
24038381
11.

Spinal cord FAAH in normal micturition control and bladder overactivity in awake rats.

Füllhase C, Russo A, Castiglione F, Benigni F, Campeau L, Montorsi F, Gratzke C, Bettiga A, Stief C, Andersson KE, Hedlund P.

J Urol. 2013 Jun;189(6):2364-70. doi: 10.1016/j.juro.2012.11.165. Epub 2012 Dec 3.

PMID:
23219540
12.

Reply to Manish Garg, Apul Goel and Jai Prakash's letter to the editor re: Renzo Colombo, Lorenzo Rocchini, Nazareno Suardi, et al. Neoadjuvant short-term intensive intravesical mitomycin C regimen compared with weekly schedule for low-grade recurrent non-muscle-invasive bladder cancer: preliminary results of a randomised phase 2 study. Eur Urol 2012;62:797-802.

Colombo R, Rocchini L, Suardi N, Benigni F, Colciago G, Bettiga A, Pellucchi F, Maccagnano C, Briganti A, Salonia A, Rigatti P, Montorsi F.

Eur Urol. 2013 Jan;63(1):e7-8. doi: 10.1016/j.eururo.2012.09.029. Epub 2012 Sep 23. No abstract available.

PMID:
23092542
13.

Neoadjuvant short-term intensive intravesical mitomycin C regimen compared with weekly schedule for low-grade recurrent non-muscle-invasive bladder cancer: preliminary results of a randomised phase 2 study.

Colombo R, Rocchini L, Suardi N, Benigni F, Colciago G, Bettiga A, Pellucchi F, Maccagnano C, Briganti A, Salonia A, Rigatti P, Montorsi F.

Eur Urol. 2012 Nov;62(5):797-802. doi: 10.1016/j.eururo.2012.05.032. Epub 2012 May 18. Erratum in: Eur Urol. 2019 Mar;75(3):e81.

PMID:
22633362
14.

Perioperative betamethasone treatment reduces signs of bladder dysfunction in a rat model for neurapraxia in female urogenital surgery.

Castiglione F, Bergamini A, Bettiga A, Bivalacqua TJ, Benigni F, Strittmatter F, Gandaglia G, Rigatti P, Montorsi F, Hedlund P.

Eur Urol. 2012 Dec;62(6):1076-85. doi: 10.1016/j.eururo.2012.04.037. Epub 2012 Apr 19.

15.

Expression of fatty acid amide hydrolase (FAAH) in human, mouse, and rat urinary bladder and effects of FAAH inhibition on bladder function in awake rats.

Strittmatter F, Gandaglia G, Benigni F, Bettiga A, Rigatti P, Montorsi F, Gratzke C, Stief C, Colciago G, Hedlund P.

Eur Urol. 2012 Jan;61(1):98-106. doi: 10.1016/j.eururo.2011.09.002. Epub 2011 Sep 12.

PMID:
21930339
16.

Brain lipid composition in grey-lethal mutant mouse characterized by severe malignant osteopetrosis.

Prinetti A, Rocchetta F, Costantino E, Frattini A, Caldana E, Rucci F, Bettiga A, Poliani PL, Chigorno V, Sonnino S.

Glycoconj J. 2009 Aug;26(6):623-33. doi: 10.1007/s10719-008-9179-8. Epub 2008 Sep 10.

PMID:
18781385
17.

Reorganization of prion protein membrane environment during low potassium-induced apoptosis in primary rat cerebellar neurons.

Rivaroli A, Prioni S, Loberto N, Bettiga A, Chigorno V, Prinetti A, Sonnino S.

J Neurochem. 2007 Dec;103(5):1954-67. Epub 2007 Sep 13.

18.

4-oxo-fenretinide, a recently identified fenretinide metabolite, induces marked G2-M cell cycle arrest and apoptosis in fenretinide-sensitive and fenretinide-resistant cell lines.

Villani MG, Appierto V, Cavadini E, Bettiga A, Prinetti A, Clagett-Dame M, Curley RW, Formelli F.

Cancer Res. 2006 Mar 15;66(6):3238-47.

19.

Lack of ceramide generation and altered sphingolipid composition are associated with drug resistance in human ovarian carcinoma cells.

Prinetti A, Millimaggi D, D'Ascenzo S, Clarkson M, Bettiga A, Chigorno V, Sonnino S, Pavan A, Dolo V.

Biochem J. 2006 Apr 15;395(2):311-8.

20.

The membrane environment of endogenous cellular prion protein in primary rat cerebellar neurons.

Loberto N, Prioni S, Bettiga A, Chigorno V, Prinetti A, Sonnino S.

J Neurochem. 2005 Nov;95(3):771-83.

21.

The analgesic tramadol has minimal effect on gastrointestinal motor function.

Wilder-Smith CH, Bettiga A.

Br J Clin Pharmacol. 1997 Jan;43(1):71-5.

Supplemental Content

Loading ...
Support Center